Prenatal exposure to PPIs and H2 receptor antagonists were not found to increase risk for neuropsychiatric disorders in offspring.

Palatin Technologies, Inc. , a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system, today announced ...

Advancing differentiated MC4R-based obesity programs into clinical development Melanocortin-based obesity therapies targeting rare MC4R pathway disorders with a primary ...

The Jharkhand Academic Council (JAC) successfully conducted the JAC Class 12 Computer Science Exam 2026 on 17th February 2026 ...

Your zip code can be more powerful than your genetic code when determining the health outcomes of mother and baby.

Today’s Forbes Daily also covers Anthropic’s hot streak, a junk bond master, Les Wexner’s upcoming Epstein deposition, cutting edge bobsled engineering and more.

Background Secondary prevention is critical for patients with established atherosclerotic cardiovascular diseases (ASCVD).